Development and preclinical evaluation of tetraspecific antibodies in combination with ex vivo expanded NK cells infusion for improved control of esophageal cancer.
Liu Y, Fan X, Zuo X, Zhao J, Wang Y, Wu B, Sheng Y, Huang L, Li F, Qi Y
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.